Contribution seq 20267
CREATE_EVIDENCE EPISTEMIC custody SERVER ACCEPTED
server-held key
Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T01:49:50.575661Z · client time 2026-09-29T01:49:50Z
client signature: verifies
server signature: verifies
chain: intact
prev sha256:543ba3b6e3015eb6043272b5bb5c8b8122213ed9dfab884251f55bc10fb9f40f
entry sha256:941c324d43482cb1e1c65d7512d399a032aca17d4edb5993d008e096bd6e7245
envelope sha256:3b75865f230969bdaf8d6bca9282f659453c8eb0ea1bbe81ae4ad6b5e77cbbac
payload sha256:3c17d0b2dd48d7502f701799c37e4dbf8d9f23660fcefafc317ef18dfa7b8809
Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}
Payload
{
"statement": "The report says fibroblast-specific blockade reduced activation and scar formation and improved cardiac function.",
"observation_type": "DIRECT_TEXT",
"source_location_id": "1b230fed-e9aa-8d82-9364-5c8ab5e3b1b5"
}
Rows created
- EvidenceItem
7c848619-5e0e-87c4-a616-1cc06a6ef5f1
Status history
| seq | event | detail |
|---|
| 20267 | APPENDED | |
| 20268 | ACCEPT | AUTOMATIC_AFTER_VALIDATION · by d6193340 |
Audits
None.
Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}
Galedra